3 Penny Stocks Primed for Explosive Moves - November 13, 2025 Watchlist
Micro-cap rockets or ticking time bombs? These sub-dollar plays could make or break portfolios this week.
The High-Risk, High-Reward Game
While Wall Street's darlings hog the spotlight, penny stocks lurk in the shadows—volatile, thinly traded, and packing 10x potential (or catastrophic losses). Today's picks defy conventional wisdom.
#1: The Dark Horse Disruptor
Trading at just $0.47 with 300% weekly volume spikes, this biotech wildcard could either cure cancer or cure investors of their life savings.
#2: The AI Afterthought
Forgotten in the AI arms race, this $0.89 semiconductor play now whispers about an unannounced Tesla partnership—classic pump fuel or legitimate breakout?
#3: The Zombie Resurrection
Left for dead at $0.12 last quarter, this energy play suddenly boasts 'revolutionary' battery tech. Because nothing screams credibility like a penny stock press release.
Remember: In penny stock land, 'due diligence' often means checking if the CEO has been indicted—yet somehow, these casino chips keep printing millionaires (and bagholders).
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The Penny Stock Screener enables investors to identify stocks using various filters such as Sector, Price Target Upside, Smart Score, Analyst Consensus, Dollar Volume, and Price Change.
We Leveraged the tool to identify the top three penny stocks with the highest Dollar Volume as of market close on November 12, 2025. Dollar Volume refers to the total value of shares traded in a day, calculated by multiplying the number of shares traded by the stock’s price.
(LPTX) – Leap Therapeutics is a biopharmaceutical company focused on developing treatments for cancer. On November 12, LPTX had a Dollar Volume of $1.61 billion, while its share price rocketed more than 368%.
The company’s stock jumped sharply after it announced several major updates. It plans to expand into digital asset investments while continuing its cancer drug research. As part of this rebranding, the company will change its name to “Cypherpunk Technologies” and trade under the ticker symbol “CYPH.”
(AMZE) – Amaze Holdings operates as an end-to-end, creator-powered commerce platform that offers tools for seamless product creation and advanced e-commerce solutions. Yesterday, AMZE had a Dollar Volume of $109.55 million, while its stock price dropped by nearly 17%.
Amaze’s shares fell despite announcing the acquisition of the assets of The Food Channel for $650,000, payable in the FORM of a convertible promissory note issued by Amaze. This purchase helps Amaze grow into new creator areas by combining its food creators with The Food Channel’s well-known brand to build a next-gen social commerce and entertainment platform.
(SLRX) – Salarius Pharmaceuticals is clinical-stage pharmaceutical company focused on developing novel treatments for cancer. On Wednesday, SLRX had a Dollar Volume of $88.35 million, accompanied by a stock price gain of 17.4%.
The share price gain seems to be a reversal from Salarius’ massive drop of 51% recorded on November 11. The company announced an underwritten public offering, selling 2.51 million shares and special pre-funded warrants to buy another 2.15 million shares at $1.50 each, raising about $7 million. The funds will be used to develop Salarius’ and Decoy’s research programs, pay off some of Decoy’s debts, and cover other general business expenses.
To find more penny stocks like these, you can take a look at TipRanks’ Penny Stock Screener tool. It shows a list of all penny stocks, their price movement, and other vital data.
